Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism. [electronic resource] by
- Gross, C Michael
- Perrot, Andreas
- Geier, Christian
- Posch, Maximillian G
- Hassfeld, Sabine
- Kramer, Jochen
- Schmidt, Sibylle
- Derer, Wolfgang
- Dietz, Rainer
- Ozcelik, Cemil
Producer: 20070828
In:
The Journal of invasive cardiology vol. 19
Availability: No items available.
|
|
11.
|
The CAIRP (CAndesartan for In-stent Restenosis Prevention) Trial--a multicenter study of AT1-receptor blocker therapy in coronary stenting. [electronic resource] by
- Krämer, Jochen
- Ruf, Rainer G
- Schmidt, Sibylle
- Axthelm, Christoph
- Strasser, Ruth
- Janssen, Gerhard
- Thieme, Torsten
- Kusch, Angelika
- Waigand, Jürgen
- Dietz, Rainer
- Gross, C Michael
Producer: 20080715
In:
The Journal of invasive cardiology vol. 20
Availability: No items available.
|